Terms: = Liver cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
462 results:
1. UBXN1 promotes liver tumorigenesis by regulating mitochondrial homeostasis.
Jiao K; Xu G; Liu Y; Yang Z; Xiang L; Chen Z; Xu C; Zuo Y; Wu Z; Zheng N; Xu W; Zhang L; Liu Y
J Transl Med; 2024 May; 22(1):485. PubMed ID: 38773518
[TBL] [Abstract] [Full Text] [Related]
2. Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis.
Sangineto M; Ciarnelli M; Colangelo T; Moola A; Bukke VN; Duda L; Villani R; Romano A; Giandomenico S; Kanwal H; Serviddio G
Cell Rep Med; 2024 May; 5(5):101564. PubMed ID: 38733988
[TBL] [Abstract] [Full Text] [Related]
3. DNAJC24 acts directly with PCNA and promotes malignant progression of LUAD by activating phosphorylation of AKT.
Liu D; Zuo R; Liu W; He Y; Wang Y; Yue P; Gong W; Cui J; Zhu F; Luo Y; Qi L; Guo Y; Chen L; Li G; Liu Z; Chen P; Guo H
FASEB J; 2024 May; 38(9):e23630. PubMed ID: 38713100
[TBL] [Abstract] [Full Text] [Related]
4. RAC1
Shi X; Chen W; Yin Y; Cao H; Wang X; Jiang W; Li Q; Li X; Yu Y; Wang X
Cancer Lett; 2024 Jun; 592():216909. PubMed ID: 38679407
[TBL] [Abstract] [Full Text] [Related]
5. Apoptotic Effect of Isoimpertorin via Inhibition of c-Myc and SIRT1 Signaling Axis.
Ko HJ; Park SY; Sim DY; Kim SH; Hur S; Lee JH; Kim Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673833
[TBL] [Abstract] [Full Text] [Related]
6. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
7. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract] [Full Text] [Related]
8. How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study.
Shi Y; Wang Y; Niu K; Zhang W; Lv Q; Zhang Y
Comput Biol Med; 2024 Apr; 172():108260. PubMed ID: 38492457
[TBL] [Abstract] [Full Text] [Related]
9. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
Meng W; Lu X; Wang G; Xiao Q; Gao J
Funct Integr Genomics; 2024 Mar; 24(2):53. PubMed ID: 38453820
[TBL] [Abstract] [Full Text] [Related]
10. Predicting microvascular invasion in hepatocellular carcinoma with a CT- and MRI-based multimodal deep learning model.
Lei Y; Feng B; Wan M; Xu K; Cui J; Ma C; Sun J; Yao C; Gan S; Shi J; Cui E
Abdom Radiol (NY); 2024 May; 49(5):1397-1410. PubMed ID: 38433144
[TBL] [Abstract] [Full Text] [Related]
11. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation.
Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
[TBL] [Abstract] [Full Text] [Related]
12. Alpha-fetoprotein upregulates hepatocellular carcinoma cell-intrinsic PD-1 expression through the LATS2/YAP/TEAD1 pathway.
Leng G; Gong H; Liu G; Kong Y; Guo L; Zhang Y
Biochim Biophys Acta Gen Subj; 2024 May; 1868(5):130592. PubMed ID: 38395204
[TBL] [Abstract] [Full Text] [Related]
13. RARRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2.
Guo Y; Chai B; Zhang H; Chai X; Chen Y; Xu J; Qin L; Chai Y
Biol Direct; 2024 Feb; 19(1):15. PubMed ID: 38388961
[TBL] [Abstract] [Full Text] [Related]
14. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
15. New daphnane diterpenoidal 1,3,4-oxdiazole derivatives as potential anti-hepatoma agents: Synthesis, biological evaluation and molecular modeling studies.
Wang X; Wang Y; Liu Z; Zhao H; Yao GD; Liu Q; Song SJ
Bioorg Chem; 2024 Apr; 145():107208. PubMed ID: 38354501
[TBL] [Abstract] [Full Text] [Related]
16. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.
Tao S; Cui D; Cheng H; Liu X; Jiang Z; Chen H; Gao Y
BMC Cancer; 2024 Feb; 24(1):194. PubMed ID: 38347489
[TBL] [Abstract] [Full Text] [Related]
17. Ubiquitination-specific protease 7 enhances stemness of hepatocellular carcinoma by stabilizing basic transcription factor 3.
Hu M; Dai C; Sun X; Chen Y; Xu N; Lin Z; Xu S; Cheng C; Tan Z; Bian S; Zheng W
Funct Integr Genomics; 2024 Feb; 24(1):28. PubMed ID: 38340226
[TBL] [Abstract] [Full Text] [Related]
18. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.
Ou X; Tan Y; Xie J; Yuan J; Deng X; Shao R; Song C; Cao X; Xie X; He R; Li Y; Tang H
Drug Resist Updat; 2024 Mar; 73():101063. PubMed ID: 38335844
[TBL] [Abstract] [Full Text] [Related]
19. HBV promotes its replication by up-regulating RAD51C gene expression.
Peng TW; Ma QF; Li J; Wang X; Zhang CH; Ma J; Li JY; Wang W; Zhu CL; Liu XH
Sci Rep; 2024 Jan; 14(1):2607. PubMed ID: 38297111
[TBL] [Abstract] [Full Text] [Related]
20. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1.
Liu T; Zhai C; Tian B; Li C; Han S; Wang S; Xuan M; Liu D; Zhao Y; Zhao H; Yu W; Wang J
Sci Rep; 2024 Jan; 14(1):2588. PubMed ID: 38297025
[TBL] [Abstract] [Full Text] [Related]
[Next]
